Natural Product: NPC270511
Natural Product ID:   | NPC270511 |
Common Name*:   | FWPYIYVSYQRISA-LEOBWYFPSA-N |
IUPAC Name:   | n.a. |
Synonyms:   | |
Standard InCHIKey:   | FWPYIYVSYQRISA-LEOBWYFPSA-N |
Standard InCHI:   | InChI=1S/C28H42O3/c1-18(2)19(3)7-8-20(4)22-9-10-23-25(22,5)13-12-24-26(6)14-11-21(29)17-27(26)15-16-28(23,24)31-30-27/h7-8,12,15-16,18-23,29H,9-11,13-14,17H2,1-6H3/b8-7+/t19-,20+,21-,22+,23+,25+,26+,27+,28-/m0/s1 |
SMILES:   | O[C@H]1CC[C@]2([C@@]3(C1)OO[C@@]1(C2=CC[C@]2([C@H]1CC[C@@H]2[C@@H](/C=C/[C@@H](C(C)C)C)C)C)C=C3)C
|
Synthetic Gene Cluster:   |
n.a. |
ChEMBL Identifier:   |
CHEMBL449356 |
PubChem CID:   |
11112737 |
Chemical Classification**:   |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0000012] Lipids and lipid-like molecules
-
[CHEMONTID:0000258] Steroids and steroid derivatives
[CHEMONTID:0003567] Ergostane steroids
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
DOI[10.1016/j.phytochem.2005.10.025] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
fruit body |
n.a. |
PMID[11520245] |
NPO21301 |
Stereum hirsutum |
Species |
Stereaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[12003003] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[12045343] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[14695801] |
NPO21558 |
Ormosia sumatrana |
Species |
Fabaceae |
Eukaryota |
leaves |
n.a. |
n.a. |
PMID[15568789] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[1791484] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
spore |
n.a. |
PMID[18827358] |
NPO19990 |
Axinyssa isabela |
Species |
Halichondriidae |
Eukaryota |
n.a. |
Isla Isabel (Gulf of California, Mexico) |
n.a. |
PMID[19007287] |
NPO9838 |
Eucalyptus maideni |
Species |
Myrtaceae |
Eukaryota |
fresh leaves |
n.a. |
n.a. |
PMID[19778089] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
fruiting bodies |
Nagano, Japan |
2008-MAY |
PMID[20039640] |
NPO9838 |
Eucalyptus maideni |
Species |
Myrtaceae |
Eukaryota |
fresh fruits |
n.a. |
n.a. |
PMID[20092288] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[20384295] |
NPO20954 |
Haloxylon salicornicum |
Species |
Chenopodiaceae |
Eukaryota |
whole plant |
Cholistan desert near district Bahawalpur (Punjab), Pakistan |
2003-Oct |
PMID[20542692] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
fruiting bodies |
n.a. |
n.a. |
PMID[20702092] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
fruiting bodies |
n.a. |
n.a. |
PMID[21924611] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[22014750] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
fruit body |
n.a. |
PMID[22044278] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
fruiting body |
n.a. |
n.a. |
PMID[22047696] |
NPO32523 |
solanum violaceum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[22413887] |
NPO32523 |
solanum violaceum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[23511021] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[25565282] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[26222905] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
Mycelia |
n.a. |
n.a. |
PMID[26807743] |
NPO40805 |
Calvatia nipponica |
Species |
n.a. |
n.a. |
Fruiting Bodies |
n.a. |
n.a. |
PMID[32940037] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
Fruiting Bodies |
n.a. |
n.a. |
PMID[33246107] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
fruit body |
n.a. |
PMID[9635497] |
NPO4994 |
Pachysandra procumbens |
Species |
Buxaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[9784163] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO18460 |
Trema dielsiana |
Species |
Cannabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO20954 |
Haloxylon salicornicum |
Species |
Chenopodiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO21301 |
Stereum hirsutum |
Species |
Stereaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO18460 |
Trema dielsiana |
Species |
Cannabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO16609 |
Ganoderma sinense |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO20276 |
Burasaia madagascariensis |
Species |
Menispermaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO17541 |
Andryala pinnatifida |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18460 |
Trema dielsiana |
Species |
Cannabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO1493 |
Hericium erinaceus |
Species |
Hericiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO20954 |
Haloxylon salicornicum |
Species |
Chenopodiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO20747 |
Stictocardia campanulata |
Species |
Convolvulaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO9838 |
Eucalyptus maideni |
Species |
Myrtaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO25269 |
Ganoderma lucidum |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO16609 |
Ganoderma sinense |
Species |
Ganodermataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO13404 |
Plantago subulata |
Species |
Plantaginaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21238 |
Berberis tabiensis |
Species |
Berberidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO4994 |
Pachysandra procumbens |
Species |
Buxaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO19796 |
Azolla filiculoides |
Species |
Azollaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21431 |
Rapanea laetevirens |
Species |
Primulaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21490 |
Hypoxylon fragiforme |
Species |
Xylariaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21301 |
Stereum hirsutum |
Species |
Stereaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO19031 |
Thymus marschallianus |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18857 |
Pteronia eenii |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO19907 |
Helicobasidium mompa |
Species |
Helicobasidiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO19990 |
Axinyssa isabela |
Species |
Halichondriidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO20485 |
Cussonia arborea |
Species |
Araliaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18114 |
Cyclamen repandum |
Species |
Primulaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21558 |
Ormosia sumatrana |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO24508 |
Aspergillus brunneus |
Species |
Aspergillaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
Organism ID |
NP ID |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  Biological Activity
Activity Type |
# Activity |
IC50 |
5 |
MIC |
6 |
Activity Type |
# Activity |
Cell Line |
4 |
NON-MOLECULAR |
1 |
Organism |
6 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT82 |
Cell Line |
MDA-MB-231 |
Homo sapiens |
IC50 |
= |
7.32 |
ug.mL-1 |
PMID[564090] |
NPT81 |
Cell Line |
A549 |
Homo sapiens |
IC50 |
= |
10.37 |
ug.mL-1 |
PMID[564090] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
9.18 |
ug.mL-1 |
PMID[564090] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
IC50 |
= |
7.73 |
ug.mL-1 |
PMID[564090] |
NPT88 |
Organism |
Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
= |
16.0 |
ug.mL-1 |
PMID[564088] |
NPT16 |
Organism |
Staphylococcus aureus |
Staphylococcus aureus |
MIC |
> |
512.0 |
ug.mL-1 |
PMID[564088] |
NPT19 |
Organism |
Escherichia coli |
Escherichia coli |
MIC |
> |
512.0 |
ug.mL-1 |
PMID[564088] |
NPT18 |
Organism |
Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
> |
512.0 |
ug.mL-1 |
PMID[564088] |
NPT787 |
Organism |
Candida |
Candida |
MIC |
> |
512.0 |
ug.mL-1 |
PMID[564088] |
NPT88 |
Organism |
Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
= |
100.0 |
ug.mL-1 |
PMID[564089] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
15.52 |
ug.mL-1 |
PMID[564090] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
  Chemically structural similarity: I. Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC270511 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 183 |
0.1-0.2 | 1436 |
0.2-0.3 | 5264 |
0.3-0.4 | 14827 |
0.4-0.5 | 9502 |
0.5-0.6 | 6317 |
0.6-0.7 | 4217 |
0.7-0.8 | 838 |
0.8-0.85 | 79 |
0.85-0.9 | 24 |
0.9-0.95 | 5 |
0.95-1 | 5 |
  Chemically structural similarity: II. Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC270511 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 180 |
0.1-0.2 | 1601 |
0.2-0.3 | 4277 |
0.3-0.4 | 2188 |
0.4-0.5 | 500 |
0.5-0.6 | 195 |
0.6-0.7 | 161 |
0.7-0.8 | 42 |
0.8-0.85 | 6 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8161 |
Intermediate Similarity |
NPD7525 |
Registered |
0.8 |
Intermediate Similarity |
NPD6942 |
Approved |
0.8 |
Intermediate Similarity |
NPD7339 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6931 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6930 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD7514 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD4751 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD6929 |
Approved |
0.7816 |
Intermediate Similarity |
NPD6932 |
Approved |
0.7802 |
Intermediate Similarity |
NPD7338 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD7332 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD7145 |
Approved |
0.7701 |
Intermediate Similarity |
NPD3701 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6695 |
Phase 3 |
0.7667 |
Intermediate Similarity |
NPD6902 |
Approved |
0.764 |
Intermediate Similarity |
NPD7645 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD5776 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD6925 |
Approved |
0.7556 |
Intermediate Similarity |
NPD4748 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD6893 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6926 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4784 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6924 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4785 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6683 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD4786 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8264 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7524 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7750 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD6933 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6898 |
Phase 1 |
0.7245 |
Intermediate Similarity |
NPD6079 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7150 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7151 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7152 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4243 |
Approved |
0.7216 |
Intermediate Similarity |
NPD5328 |
Approved |
0.7204 |
Intermediate Similarity |
NPD3667 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7509 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4202 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7322 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7144 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7143 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5211 |
Phase 2 |
0.7087 |
Intermediate Similarity |
NPD5285 |
Approved |
0.7087 |
Intermediate Similarity |
NPD5286 |
Approved |
0.7087 |
Intermediate Similarity |
NPD4696 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3618 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD7087 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD4755 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6923 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6922 |
Approved |
0.6991 |
Remote Similarity |
NPD7328 |
Approved |
0.6991 |
Remote Similarity |
NPD7327 |
Approved |
0.699 |
Remote Similarity |
NPD7638 |
Approved |
0.6981 |
Remote Similarity |
NPD5141 |
Approved |
0.6952 |
Remote Similarity |
NPD5225 |
Approved |
0.6952 |
Remote Similarity |
NPD5226 |
Approved |
0.6952 |
Remote Similarity |
NPD5224 |
Approved |
0.6952 |
Remote Similarity |
NPD4633 |
Approved |
0.693 |
Remote Similarity |
NPD7516 |
Approved |
0.6923 |
Remote Similarity |
NPD4700 |
Approved |
0.6923 |
Remote Similarity |
NPD7640 |
Approved |
0.6923 |
Remote Similarity |
NPD7639 |
Approved |
0.69 |
Remote Similarity |
NPD7637 |
Suspended |
0.6887 |
Remote Similarity |
NPD5174 |
Approved |
0.6887 |
Remote Similarity |
NPD5175 |
Approved |
0.6882 |
Remote Similarity |
NPD4195 |
Approved |
0.6857 |
Remote Similarity |
NPD5223 |
Approved |
0.6832 |
Remote Similarity |
NPD6399 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD4634 |
Approved |
0.6813 |
Remote Similarity |
NPD5275 |
Approved |
0.6813 |
Remote Similarity |
NPD4190 |
Phase 3 |
0.681 |
Remote Similarity |
NPD8379 |
Approved |
0.681 |
Remote Similarity |
NPD8335 |
Approved |
0.681 |
Remote Similarity |
NPD8378 |
Approved |
0.681 |
Remote Similarity |
NPD8296 |
Approved |
0.681 |
Remote Similarity |
NPD8033 |
Approved |
0.681 |
Remote Similarity |
NPD8380 |
Approved |
0.681 |
Remote Similarity |
NPD7503 |
Approved |
0.6804 |
Remote Similarity |
NPD7520 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD5222 |
Approved |
0.6796 |
Remote Similarity |
NPD5221 |
Approved |
0.6796 |
Remote Similarity |
NPD5220 |
Clinical (unspecified phase) |
0.6789 |
Remote Similarity |
NPD6899 |
Approved |
0.6789 |
Remote Similarity |
NPD6881 |
Approved |
0.6759 |
Remote Similarity |
NPD6402 |
Approved |
0.6759 |
Remote Similarity |
NPD6675 |
Approved |
0.6759 |
Remote Similarity |
NPD5739 |
Approved |
0.6759 |
Remote Similarity |
NPD7128 |
Approved |
0.6754 |
Remote Similarity |
NPD7115 |
Discovery |
0.6735 |
Remote Similarity |
NPD5279 |
Phase 3 |
0.6731 |
Remote Similarity |
NPD5173 |
Approved |
0.6724 |
Remote Similarity |
NPD8294 |
Approved |
0.6724 |
Remote Similarity |
NPD8377 |
Approved |
0.6701 |
Remote Similarity |
NPD3665 |
Phase 1 |
0.6701 |
Remote Similarity |
NPD3133 |
Approved |
0.6701 |
Remote Similarity |
NPD3666 |
Approved |
0.67 |
Remote Similarity |
NPD4753 |
Phase 2 |
0.6698 |
Remote Similarity |
NPD4159 |
Approved |
0.6697 |
Remote Similarity |
NPD5697 |
Approved |
0.6667 |
Remote Similarity |
NPD6883 |
Approved |
0.6667 |
Remote Similarity |
NPD7290 |
Approved |
0.6667 |
Remote Similarity |
NPD7102 |
Approved |
0.6636 |
Remote Similarity |
NPD4729 |
Approved |
0.6636 |
Remote Similarity |
NPD4730 |
Approved |
0.6636 |
Remote Similarity |
NPD7320 |
Approved |
0.6635 |
Remote Similarity |
NPD4697 |
Phase 3 |
0.6634 |
Remote Similarity |
NPD7136 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD4267 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD6617 |
Approved |
0.6607 |
Remote Similarity |
NPD6847 |
Approved |
0.6607 |
Remote Similarity |
NPD6650 |
Approved |
0.6607 |
Remote Similarity |
NPD6869 |
Approved |
0.6607 |
Remote Similarity |
NPD8130 |
Phase 1 |
0.6607 |
Remote Similarity |
NPD6649 |
Approved |
0.6606 |
Remote Similarity |
NPD4767 |
Approved |
0.6606 |
Remote Similarity |
NPD4768 |
Approved |
0.6588 |
Remote Similarity |
NPD368 |
Approved |
0.6577 |
Remote Similarity |
NPD6372 |
Approved |
0.6577 |
Remote Similarity |
NPD6373 |
Approved |
0.6577 |
Remote Similarity |
NPD6012 |
Approved |
0.6577 |
Remote Similarity |
NPD6014 |
Approved |
0.6577 |
Remote Similarity |
NPD6013 |
Approved |
0.6574 |
Remote Similarity |
NPD4754 |
Approved |
0.6569 |
Remote Similarity |
NPD7515 |
Phase 2 |
0.6566 |
Remote Similarity |
NPD5690 |
Phase 2 |
0.6549 |
Remote Similarity |
NPD6882 |
Approved |
0.6549 |
Remote Similarity |
NPD8297 |
Approved |
0.6545 |
Remote Similarity |
NPD5701 |
Approved |
0.6545 |
Remote Similarity |
NPD6412 |
Phase 2 |
0.6538 |
Remote Similarity |
NPD4629 |
Approved |
0.6538 |
Remote Similarity |
NPD5210 |
Approved |
0.6535 |
Remote Similarity |
NPD6051 |
Approved |
0.6531 |
Remote Similarity |
NPD3668 |
Phase 3 |
0.6518 |
Remote Similarity |
NPD5251 |
Approved |
0.6518 |
Remote Similarity |
NPD5247 |
Approved |
0.6518 |
Remote Similarity |
NPD5250 |
Approved |
0.6518 |
Remote Similarity |
NPD5248 |
Approved |
0.6518 |
Remote Similarity |
NPD5249 |
Phase 3 |
0.6509 |
Remote Similarity |
NPD5290 |
Discontinued |
0.6495 |
Remote Similarity |
NPD4221 |
Approved |
0.6495 |
Remote Similarity |
NPD4223 |
Phase 3 |
0.6491 |
Remote Similarity |
NPD4632 |
Approved |
0.6486 |
Remote Similarity |
NPD6011 |
Approved |
0.6486 |
Remote Similarity |
NPD5128 |
Approved |
0.6465 |
Remote Similarity |
NPD5329 |
Approved |
0.646 |
Remote Similarity |
NPD5215 |
Approved |
0.646 |
Remote Similarity |
NPD5216 |
Approved |
0.646 |
Remote Similarity |
NPD5217 |
Approved |
0.6446 |
Remote Similarity |
NPD7507 |
Approved |
0.6441 |
Remote Similarity |
NPD6054 |
Approved |
0.6423 |
Remote Similarity |
NPD7319 |
Approved |
0.6415 |
Remote Similarity |
NPD6084 |
Phase 2 |
0.6415 |
Remote Similarity |
NPD6083 |
Phase 2 |
0.6413 |
Remote Similarity |
NPD4732 |
Discontinued |
0.6408 |
Remote Similarity |
NPD5284 |
Approved |
0.6408 |
Remote Similarity |
NPD8034 |
Phase 2 |
0.6408 |
Remote Similarity |
NPD6411 |
Approved |
0.6408 |
Remote Similarity |
NPD5281 |
Approved |
0.6408 |
Remote Similarity |
NPD8035 |
Phase 2 |
0.64 |
Remote Similarity |
NPD5280 |
Approved |
0.64 |
Remote Similarity |
NPD4694 |
Approved |
0.6389 |
Remote Similarity |
NPD5344 |
Discontinued |
0.6381 |
Remote Similarity |
NPD5695 |
Phase 3 |
0.6372 |
Remote Similarity |
NPD5169 |
Approved |
0.6372 |
Remote Similarity |
NPD5134 |
Clinical (unspecified phase) |
0.6372 |
Remote Similarity |
NPD5135 |
Approved |
0.6364 |
Remote Similarity |
NPD4197 |
Approved |
0.6346 |
Remote Similarity |
NPD5778 |
Approved |
0.6346 |
Remote Similarity |
NPD5779 |
Approved |
0.6333 |
Remote Similarity |
NPD6370 |
Approved |
0.633 |
Remote Similarity |
NPD7632 |
Discontinued |
0.6325 |
Remote Similarity |
NPD6009 |
Approved |
0.6316 |
Remote Similarity |
NPD5127 |
Approved |
0.6316 |
Remote Similarity |
NPD6401 |
Clinical (unspecified phase) |
0.6306 |
Remote Similarity |
NPD6008 |
Approved |
0.6303 |
Remote Similarity |
NPD6059 |
Approved |
0.6303 |
Remote Similarity |
NPD6319 |
Approved |
0.6289 |
Remote Similarity |
NPD4821 |
Approved |
0.6289 |
Remote Similarity |
NPD4822 |
Approved |
0.6289 |
Remote Similarity |
NPD4819 |
Approved |
0.6289 |
Remote Similarity |
NPD6928 |
Phase 2 |
0.6289 |
Remote Similarity |
NPD4820 |
Approved |
0.6286 |
Remote Similarity |
NPD7748 |
Approved |
0.6283 |
Remote Similarity |
NPD4061 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD4788 |
Approved |
0.6262 |
Remote Similarity |
NPD7902 |
Approved |
0.6261 |
Remote Similarity |
NPD6053 |
Discontinued |
0.625 |
Remote Similarity |
NPD6016 |
Approved |
0.625 |
Remote Similarity |
NPD6015 |
Approved |
0.6238 |
Remote Similarity |
NPD5205 |
Approved |
0.6238 |
Remote Similarity |
NPD4689 |
Approved |
0.6238 |
Remote Similarity |
NPD4693 |
Phase 3 |
0.6238 |
Remote Similarity |
NPD4623 |
Approved |
0.6238 |
Remote Similarity |
NPD4690 |
Approved |
0.6238 |
Remote Similarity |
NPD3574 |
Clinical (unspecified phase) |
0.6238 |
Remote Similarity |
NPD4688 |
Approved |
0.6238 |
Remote Similarity |
NPD4519 |
Discontinued |
0.6238
|
Remote Similarity |
NPD4138 |
Approved |